Loading...
XNYS
SYK
Market cap125bUSD
Jul 09, Last price  
327.11USD
1D
0.08%
1Q
-3.55%
Jan 2017
173.02%
Name

Stryker Corp

Chart & Performance

D1W1MN
XNYS:SYK chart
P/E
38.63
P/S
4.99
EPS
8.47
Div Yield, %
1.04%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
11.84%
Revenues
25.12b
+11.16%
5,405,600,0006,000,500,0006,718,200,0006,723,100,0007,320,000,0008,307,000,0008,657,000,0009,021,000,0009,675,000,0009,946,000,00011,325,000,00012,444,000,00013,601,000,00014,884,000,00014,351,000,00017,108,000,00018,449,000,00020,498,000,00022,595,000,00025,116,000,000
Net income
3.25b
+8.45%
777,700,0001,017,400,0001,147,800,0001,107,400,0001,273,400,0001,345,000,0001,298,000,0001,006,000,000515,000,0001,439,000,0001,647,000,0001,020,000,0003,553,000,0002,083,000,0001,599,000,0001,994,000,0002,358,000,0003,165,000,0002,993,000,0003,246,000,000
CFO
5.04b
+18.91%
867,300,0001,028,300,0001,175,900,0001,460,700,0001,547,400,0001,434,000,0001,657,000,0001,886,000,0001,782,000,000899,000,0001,915,000,0001,559,000,0002,610,000,0002,191,000,0003,277,000,0003,263,000,0002,624,000,0003,711,000,0004,242,000,0005,044,000,000
Dividend
Dec 31, 20250.88 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
IPO date
Mar 17, 1980
Employees
51,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT